Țară: Statele Unite ale Americii
Limbă: engleză
Sursă: NLM (National Library of Medicine)
NORETHINDRONE ACETATE (UNII: 9S44LIC7OJ) (NORETHINDRONE - UNII:T18F433X4S), ETHINYL ESTRADIOL (UNII: 423D2T571U) (ETHINYL ESTRADIOL - UNII:423D2T571U)
Northstar Rx LLC
NORETHINDRONE ACETATE
NORETHINDRONE ACETATE 1 mg
PRESCRIPTION DRUG
LARIN™ Fe 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. *The authors' best guess of the percentage of women expected to experience an accidental pregnancy among couples who initiate a method (not necessarily for the first time) and who use it consistently and correctly during the first year if they do not stop for any other reason. **This term represents "typical" couples who initiate use of a method (not necessarily for the first time), who experience an accidental pregnancy during the first year if they do not stop use for any other reason. ***N/A--Data not availab
LARIN™ Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol. Each brown, biconvex, round tablet debossed with "F" on one side and "N " on the other side contains 75 mg ferrous fumarate. LARIN™ Fe 1/20 Tablets are available in the following configurations: Carton of 1 NDC 16714-406-02 Carton of 3 NDC 16714-406-03 Carton of 6 NDC 16714-406-04 Store at 20 ˚ C to 25˚ C (68˚ F to 77 ˚ F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
LARIN FE 1/20- NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE NORTHSTAR RX LLC ---------- LARIN™ FE 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS, USP AND FERROUS FUMARATE TABLETS*) *FERROUS FUMARATE TABLETS ARE NOT USP FOR DISSOLUTION. Each pale yellow tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol. Each brown tablet contains 75 mg ferrous fumarate. WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including LARIN™ Fe 1/20, are contraindicated in women who are over 35 years of age and smoke _(see CONTRAINDICATIONS and WARNINGS)._ DESCRIPTION LARIN™ Fe 1/20 is a progestogen-estrogen combination. LARIN™ Fe 1/20 provides a continuous dosage regimen consisting of 21 oral contraceptive tablets and seven ferrous fumarate tablets. The ferrous fumarate tablets are present to facilitate ease of drug administration via a 28-day regimen, are non- hormonal, and do not serve any therapeutic purpose. Each pale yellow tablet contains norethindrone acetate (17 alpha-ethinyl-19- nortestosterone acetate), 1 mg; ethinyl estradiol (17 alpha-ethinyl-1,3,5(10)-estratriene- 3,17 beta-diol), 20 mcg. Also contains polyvinyl alcohol, titanium dioxide, talc, macrogol/polyethylglycol 3350 NF, lecithin (soya), D&C Yellow No.10 Aluminum Lake, FD&C Blue No.2 Aluminum Lake, FD&C Yellow No.6 Aluminum Lake, lactose, magnesium stearate and pregelatinized corn starch. The structural formulas are as follows: Each brown placebo tablet contains ferrous fumarate, polyvinyl alcohol, talc, macrogol/polyethyleneglycol 3350 NF, lecithin (soya), iron oxide black, iron oxide yellow, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate and crospovidone. The ferrous fumarate tablets do not serve any therapeutic purpose. Citiți documentul complet